EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The clinical and genetic spectrum of autosomal-recessive TOR1A -related disorders

Afshin Saffari, Tracy Lau iD, Homa Tajsharghi, Ehsan Ghayoor Karimiani, Ariana Kariminejad, Stephanie Efthymiou iD, Giovanni Zifarelli, Tipu Sultan, Mehran Beiraghi Toosi, Sahar Sedighzadeh, Victoria Mok Siu, Juan Darío Ortigoza-Escobar und 48 weitere

Brain · 2023

DOI: 10.1093/brain/awad039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Afshin Saffari und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Dystonia, Dystonic Disorders, Nervous System Malformations. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the field of rare diseases, progress in molecular diagnostics led to the recognition that variants linked to autosomal-dominant neurodegenerative diseases of later onset can, in the context of biallelic inheritance, cause devastating neurodevelopmental disorders and infantile or childhood-onset neurodegeneration. TOR1A-associated arthrogryposis multiplex congenita 5 (AMC5) is a rare neurodevelopmental disorder arising from biallelic variants in TOR1A, a gene that in the heterozygous state is associated with torsion dystonia-1 (DYT1 or DYT-TOR1A), an early-onset dystonia with reduced penetrance. While 15 individuals with AMC5-TOR1A have been reported (less than 10 in detail), a systematic investigation of the full disease-associated spectrum has not been conducted. Here, we assess the clinical, radiological and molecular characteristics of 57 individuals from 40 families with biallelic variants in TOR1A. Median age at last follow-up was 3 years (0–24 years). Most individuals presented with severe congenital flexion contractures (95%) and variable developmental delay (79%). Motor symptoms were reported in 79% and included lower limb spasticity and pyramidal signs, as well as gait disturbances. Facial dysmorphism was an integral part of the phenotype, with key features being a broad/full nasal tip, narrowing of the forehead and full cheeks. Analysis of disease-associated manifestations delineated a phenotypic spectrum ranging from normal cognition and mild gait disturbance to congenital arthrogryposis, global developmental delay, intellectual disability, absent speech and inability to walk. In a subset, the presentation was consistent with foetal akinesia deformation sequence with severe intrauterine abnormalities. Survival was 71%, with higher mortality in males. Death occurred at a median age of 1.2 months (1 week–9 years), due to respiratory failure, cardiac arrest or sepsis. Analysis of brain MRI studies identified non-specific neuroimaging features, including a hypoplastic corpus callosum (72%), foci of signal abnormality in the subcortical and periventricular white matter (55%), diffuse white matter volume loss (45%), mega cisterna magna (36%) and arachnoid cysts (27%). The molecular spectrum included 22 distinct variants, defining a mutational hotspot in the C-terminal domain of the Torsin-1A protein. Genotype-phenotype analysis revealed an association of missense variants in the 3-helix bundle domain to an attenuated phenotype, while missense variants near the Walker A/B motif as well as biallelic truncating variants were linked to early death. In summary, this systematic cross-sectional analysis of a large cohort of individuals with biallelic TOR1A variants across a wide age-range delineates the clinical and genetic spectrum of TOR1A-related autosomal-recessive disease and highlights potential predictors for disease severity and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DystoniaDystonic DisordersNervous System MalformationsMaleHumansCross-Sectional StudiesMutationPhenotypeMolecular Chaperones

Stichwörter der Autor:innen

AMC5NDDTorsin-1Aarthrogryposis multiplex congenita 5biallelic variation

Substanzen

TOR1A protein, humanMolecular Chaperones

Autor:innen und Institutionen

  • Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Division of Child Neurology and Inherited Metabolic Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, UK.
  • School of Health Sciences, Division of Biomedicine, University of Skovde, Skovde, Sweden.
  • Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, UK.
  • Department of Medical Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran.

ORCID-Profile: Tracy Lau, Stephanie Efthymiou, Whalen Sandra, Konrad Platzer, Henry Oppermann, John Rendu, Angela Abicht, Sébastien Moutton

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • NHGRI NIH HHS
  • Medical Research Council
  • Deutsche Forschungsgemeinschaft
  • US National Institutes of Health
  • National Human Genome Research Institute
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Saffari, A., Lau, T., Tajsharghi, H., Karimiani, E. G., Kariminejad, A., Efthymiou, S., Zifarelli, G., Sultan, T., Toosi, M. B., Sedighzadeh, S., Siu, V. M., Ortigoza-Escobar, J. D., AlShamsi, A. M., Ibrahim, S., Al-Sannaa, N. A., Al-Hertani, W., Sandra, W., Tarnopolsky, M., Alavi, S., …, & Rieubland, C. (2023). The clinical and genetic spectrum of autosomal-recessive TOR1A -related disorders. Brain. https://doi.org/10.1093/brain/awad039

Vancouver

Saffari A, Lau T, Tajsharghi H, Karimiani EG, Kariminejad A, Efthymiou S, et al. The clinical and genetic spectrum of autosomal-recessive TOR1A -related disorders. Brain. 2023. doi:10.1093/brain/awad039

BibTeX
@article{Saffari2023,
  author = {Saffari, Afshin and Lau, Tracy and Tajsharghi, Homa and Karimiani, Ehsan Ghayoor and Kariminejad, Ariana and Efthymiou, Stephanie and Zifarelli, Giovanni and Sultan, Tipu and Toosi, Mehran Beiraghi and Sedighzadeh, Sahar and Siu, Victoria Mok and Ortigoza-Escobar, Juan Darío and AlShamsi, Aisha M and Ibrahim, Shahnaz and Al-Sannaa, Nouriya Abbas and Al-Hertani, Walla and Sandra, Whalen and Tarnopolsky, Mark and Alavi, Shahryar and Li, Chumei and Day-Salvatore, Debra-Lynn and Martínez-González, Maria Jesús and Levandoski, Kristin M and Bedoukian, Emma and Madan-Khetarpal, Suneeta and Idleburg, Michaela J and Menezes, Minal Juliet and Siddharth, Aishwarya and Platzer, Konrad and Oppermann, Henry and Smitka, Martin and Collins, Felicity and Lek, Monkol and Shahrooei, Mohmmad and Ghavideldarestani, Maryam and Herman, Isabella and Rendu, John and Faure, Julien and Baker, Janice and Bhambhani, Vikas and Calderwood, Laurel and Akhondian, Javad and Imannezhad, Shima and Mirzadeh, Hanieh Sadat and Hashemi, Narges and Doosti, Mohammad and Safi, Mojtaba and Ahangari, Najmeh and Torbati, Paria Najarzadeh and Abedini, Soheila and Salpietro, Vincenzo and Gulec, Elif Yilmaz and Eshaghian, Safieh and Ghazavi, Mohammadreza and Pascher, Michael T and Vogel, Marina and Abicht, Angela and Moutton, Sébastien and Bruel, Ange-Line and Rieubland, Claudine},
  title = {The clinical and genetic spectrum of autosomal-recessive TOR1A -related disorders},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awad039}
}
Kostenlos starten →